Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart

This publication has 7 references indexed in Scilit:

• Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury
  European Journal of Pharmacology, 2004
• Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
  British Journal of Cancer, 2003
• Resveratrol Induced Serine Phosphorylation Of p53 Causes Apoptosis In A Mutant p53 Prostate Cancer Cell Line
  Journal of Urology, 2002
• The Daily Oral Administration of High Doses of trans-Resveratrol to Rats for 28 Days Is Not Harmful
  Journal of Nutrition, 2002
• Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
  Carcinogenesis: Integrative Cancer Research, 1999
• Anthracycline-Induced Cardiotoxicity
  Annals of Internal Medicine, 1996
• Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)
  Biochemical Pharmacology, 1993